Opiant Pharmaceuticals: Q4 Earnings Insights

Opiant Pharmaceuticals OPNT reported its Q4 earnings results on Tuesday, March 15, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Opiant Pharmaceuticals beat estimated earnings by 1200.0%, reporting an EPS of $0.11 versus an estimate of $-0.01.

Revenue was up $3.88 million from the same period last year.

Last quarter the company beat on EPS by $0.64 which was followed by a 9.78% drop in the share price the next day.

Here's a look at Opiant Pharmaceuticals's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.08		-0.71	0.07
EPS Actual	0.56	0.31	-0.66	-0.16
Revenue Estimate	10.21M	8.20M	5.29M	9.20M
Revenue Actual	16.34M	11.26M	6.39M	9.92M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.